By Johnny Rice, Benzinga
Dennis Calvert, President & CEO of BioLargo, Inc (OTCQB: BLGO) was recently a guest on Benzinga’s All-Access.
BioLargo is a cleantech and life sciences innovator and engineering services solution provider. Its core products address Per- and Polyfluorinated Substances (PFAS) contamination, achieve advanced water and wastewater treatment, control odor and Volatile Organic Compounds (VOCs), improve air quality and control infections and infectious disease.
The company just announced its financials for the first quarter of 2023. Mr. Calvert spoke regarding the positive numbers which included a near 300% growth in revenue for the quarter year-over-year.
Watch the full interview here:
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Contact Details
Brian Loper
